nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—ABCB1—Mitomycin—urinary bladder cancer	0.186	0.357	CbGbCtD
Perindopril—BCHE—Cisplatin—urinary bladder cancer	0.153	0.294	CbGbCtD
Perindopril—ABCB1—Gemcitabine—urinary bladder cancer	0.0535	0.103	CbGbCtD
Perindopril—ABCB1—Cisplatin—urinary bladder cancer	0.0389	0.0746	CbGbCtD
Perindopril—ABCB1—Etoposide—urinary bladder cancer	0.0382	0.0733	CbGbCtD
Perindopril—ABCB1—Doxorubicin—urinary bladder cancer	0.026	0.05	CbGbCtD
Perindopril—ABCB1—Methotrexate—urinary bladder cancer	0.0252	0.0484	CbGbCtD
Perindopril—ACE—umbilical vein—urinary bladder cancer	0.0155	0.149	CbGeAlD
Perindopril—ACE—urine—urinary bladder cancer	0.0125	0.12	CbGeAlD
Perindopril—SLC15A1—epithelium—urinary bladder cancer	0.00459	0.0443	CbGeAlD
Perindopril—ACE—prostate gland—urinary bladder cancer	0.00448	0.0432	CbGeAlD
Perindopril—SLC15A1—renal system—urinary bladder cancer	0.00426	0.0411	CbGeAlD
Perindopril—SLC15A2—prostate gland—urinary bladder cancer	0.00391	0.0377	CbGeAlD
Perindopril—ACE—seminal vesicle—urinary bladder cancer	0.00379	0.0366	CbGeAlD
Perindopril—BCHE—prostate gland—urinary bladder cancer	0.00331	0.0319	CbGeAlD
Perindopril—SLC15A2—seminal vesicle—urinary bladder cancer	0.00331	0.0319	CbGeAlD
Perindopril—ACE—epithelium—urinary bladder cancer	0.00329	0.0318	CbGeAlD
Perindopril—ACE—smooth muscle tissue—urinary bladder cancer	0.00317	0.0306	CbGeAlD
Perindopril—SLC15A1—vagina—urinary bladder cancer	0.00309	0.0298	CbGeAlD
Perindopril—ACE—renal system—urinary bladder cancer	0.00306	0.0295	CbGeAlD
Perindopril—ACE—urethra—urinary bladder cancer	0.003	0.0289	CbGeAlD
Perindopril—BCHE—seminal vesicle—urinary bladder cancer	0.0028	0.027	CbGeAlD
Perindopril—SLC15A2—renal system—urinary bladder cancer	0.00266	0.0257	CbGeAlD
Perindopril—SLC15A2—urethra—urinary bladder cancer	0.00262	0.0252	CbGeAlD
Perindopril—ACE—female reproductive system—urinary bladder cancer	0.00245	0.0236	CbGeAlD
Perindopril—BCHE—smooth muscle tissue—urinary bladder cancer	0.00234	0.0226	CbGeAlD
Perindopril—SLC15A2—female reproductive system—urinary bladder cancer	0.00213	0.0206	CbGeAlD
Perindopril—SLC15A2—vagina—urinary bladder cancer	0.00193	0.0186	CbGeAlD
Perindopril—BCHE—female reproductive system—urinary bladder cancer	0.00181	0.0174	CbGeAlD
Perindopril—BCHE—vagina—urinary bladder cancer	0.00163	0.0158	CbGeAlD
Perindopril—ABCB1—prostate gland—urinary bladder cancer	0.00158	0.0152	CbGeAlD
Perindopril—ACE—lymph node—urinary bladder cancer	0.00143	0.0138	CbGeAlD
Perindopril—ABCB1—seminal vesicle—urinary bladder cancer	0.00133	0.0129	CbGeAlD
Perindopril—SLC15A2—lymph node—urinary bladder cancer	0.00125	0.012	CbGeAlD
Perindopril—ABCB1—epithelium—urinary bladder cancer	0.00116	0.0112	CbGeAlD
Perindopril—ABCB1—renal system—urinary bladder cancer	0.00108	0.0104	CbGeAlD
Perindopril—BCHE—lymph node—urinary bladder cancer	0.00106	0.0102	CbGeAlD
Perindopril—ABCB1—urethra—urinary bladder cancer	0.00106	0.0102	CbGeAlD
Perindopril—ABCB1—female reproductive system—urinary bladder cancer	0.000861	0.00831	CbGeAlD
Perindopril—ABCB1—vagina—urinary bladder cancer	0.000779	0.00751	CbGeAlD
Perindopril—ABCB1—lymph node—urinary bladder cancer	0.000504	0.00486	CbGeAlD
Perindopril—Hepatitis—Epirubicin—urinary bladder cancer	0.00022	0.000586	CcSEcCtD
Perindopril—Eye disorder—Methotrexate—urinary bladder cancer	0.00022	0.000585	CcSEcCtD
Perindopril—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00022	0.000585	CcSEcCtD
Perindopril—Tinnitus—Methotrexate—urinary bladder cancer	0.000219	0.000584	CcSEcCtD
Perindopril—Asthenia—Cisplatin—urinary bladder cancer	0.000218	0.000582	CcSEcCtD
Perindopril—Pharyngitis—Epirubicin—urinary bladder cancer	0.000218	0.000581	CcSEcCtD
Perindopril—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000218	0.000581	CcSEcCtD
Perindopril—Sweating—Doxorubicin—urinary bladder cancer	0.000217	0.000579	CcSEcCtD
Perindopril—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000217	0.000579	CcSEcCtD
Perindopril—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000217	0.000577	CcSEcCtD
Perindopril—Haematuria—Doxorubicin—urinary bladder cancer	0.000216	0.000576	CcSEcCtD
Perindopril—Urethral disorder—Epirubicin—urinary bladder cancer	0.000216	0.000574	CcSEcCtD
Perindopril—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000214	0.000571	CcSEcCtD
Perindopril—Epistaxis—Doxorubicin—urinary bladder cancer	0.000214	0.00057	CcSEcCtD
Perindopril—Angiopathy—Methotrexate—urinary bladder cancer	0.000213	0.000568	CcSEcCtD
Perindopril—Sinusitis—Doxorubicin—urinary bladder cancer	0.000213	0.000567	CcSEcCtD
Perindopril—Dizziness—Fluorouracil—urinary bladder cancer	0.000212	0.000565	CcSEcCtD
Perindopril—Visual impairment—Epirubicin—urinary bladder cancer	0.000212	0.000565	CcSEcCtD
Perindopril—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000212	0.000564	CcSEcCtD
Perindopril—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000212	0.000564	CcSEcCtD
Perindopril—Chills—Methotrexate—urinary bladder cancer	0.000211	0.000562	CcSEcCtD
Perindopril—Diarrhoea—Cisplatin—urinary bladder cancer	0.000208	0.000555	CcSEcCtD
Perindopril—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000208	0.000554	CcSEcCtD
Perindopril—Alopecia—Methotrexate—urinary bladder cancer	0.000208	0.000553	CcSEcCtD
Perindopril—Vomiting—Gemcitabine—urinary bladder cancer	0.000208	0.000553	CcSEcCtD
Perindopril—Bradycardia—Doxorubicin—urinary bladder cancer	0.000207	0.000552	CcSEcCtD
Perindopril—Mental disorder—Methotrexate—urinary bladder cancer	0.000206	0.000548	CcSEcCtD
Perindopril—Rash—Gemcitabine—urinary bladder cancer	0.000206	0.000548	CcSEcCtD
Perindopril—Dermatitis—Gemcitabine—urinary bladder cancer	0.000206	0.000548	CcSEcCtD
Perindopril—Eye disorder—Epirubicin—urinary bladder cancer	0.000206	0.000548	CcSEcCtD
Perindopril—Tinnitus—Epirubicin—urinary bladder cancer	0.000205	0.000546	CcSEcCtD
Perindopril—Malnutrition—Methotrexate—urinary bladder cancer	0.000205	0.000545	CcSEcCtD
Perindopril—Erythema—Methotrexate—urinary bladder cancer	0.000205	0.000545	CcSEcCtD
Perindopril—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000205	0.000545	CcSEcCtD
Perindopril—Headache—Gemcitabine—urinary bladder cancer	0.000205	0.000545	CcSEcCtD
Perindopril—Flushing—Epirubicin—urinary bladder cancer	0.000204	0.000544	CcSEcCtD
Perindopril—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000204	0.000544	CcSEcCtD
Perindopril—Vomiting—Fluorouracil—urinary bladder cancer	0.000204	0.000544	CcSEcCtD
Perindopril—Rhinitis—Doxorubicin—urinary bladder cancer	0.000204	0.000543	CcSEcCtD
Perindopril—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000204	0.000542	CcSEcCtD
Perindopril—Hepatitis—Doxorubicin—urinary bladder cancer	0.000204	0.000542	CcSEcCtD
Perindopril—Rash—Fluorouracil—urinary bladder cancer	0.000202	0.000539	CcSEcCtD
Perindopril—Dermatitis—Fluorouracil—urinary bladder cancer	0.000202	0.000539	CcSEcCtD
Perindopril—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000202	0.000538	CcSEcCtD
Perindopril—Headache—Fluorouracil—urinary bladder cancer	0.000201	0.000536	CcSEcCtD
Perindopril—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000201	0.000535	CcSEcCtD
Perindopril—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000201	0.000534	CcSEcCtD
Perindopril—Dysgeusia—Methotrexate—urinary bladder cancer	0.0002	0.000534	CcSEcCtD
Perindopril—Asthenia—Etoposide—urinary bladder cancer	0.0002	0.000533	CcSEcCtD
Perindopril—Angiopathy—Epirubicin—urinary bladder cancer	0.0002	0.000532	CcSEcCtD
Perindopril—Urethral disorder—Doxorubicin—urinary bladder cancer	0.0002	0.000531	CcSEcCtD
Perindopril—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000198	0.000528	CcSEcCtD
Perindopril—Back pain—Methotrexate—urinary bladder cancer	0.000198	0.000527	CcSEcCtD
Perindopril—Chills—Epirubicin—urinary bladder cancer	0.000197	0.000526	CcSEcCtD
Perindopril—Pruritus—Etoposide—urinary bladder cancer	0.000197	0.000525	CcSEcCtD
Perindopril—Arrhythmia—Epirubicin—urinary bladder cancer	0.000197	0.000523	CcSEcCtD
Perindopril—Visual impairment—Doxorubicin—urinary bladder cancer	0.000196	0.000522	CcSEcCtD
Perindopril—Alopecia—Epirubicin—urinary bladder cancer	0.000194	0.000518	CcSEcCtD
Perindopril—Nausea—Gemcitabine—urinary bladder cancer	0.000194	0.000517	CcSEcCtD
Perindopril—Vomiting—Cisplatin—urinary bladder cancer	0.000193	0.000515	CcSEcCtD
Perindopril—Mental disorder—Epirubicin—urinary bladder cancer	0.000193	0.000513	CcSEcCtD
Perindopril—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000192	0.000513	CcSEcCtD
Perindopril—Rash—Cisplatin—urinary bladder cancer	0.000192	0.000511	CcSEcCtD
Perindopril—Dermatitis—Cisplatin—urinary bladder cancer	0.000192	0.000511	CcSEcCtD
Perindopril—Malnutrition—Epirubicin—urinary bladder cancer	0.000191	0.00051	CcSEcCtD
Perindopril—Erythema—Epirubicin—urinary bladder cancer	0.000191	0.00051	CcSEcCtD
Perindopril—Diarrhoea—Etoposide—urinary bladder cancer	0.000191	0.000508	CcSEcCtD
Perindopril—Nausea—Fluorouracil—urinary bladder cancer	0.000191	0.000508	CcSEcCtD
Perindopril—Eye disorder—Doxorubicin—urinary bladder cancer	0.00019	0.000507	CcSEcCtD
Perindopril—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00019	0.000506	CcSEcCtD
Perindopril—Tinnitus—Doxorubicin—urinary bladder cancer	0.00019	0.000505	CcSEcCtD
Perindopril—Anaemia—Methotrexate—urinary bladder cancer	0.000189	0.000504	CcSEcCtD
Perindopril—Flushing—Doxorubicin—urinary bladder cancer	0.000189	0.000503	CcSEcCtD
Perindopril—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000189	0.000503	CcSEcCtD
Perindopril—Flatulence—Epirubicin—urinary bladder cancer	0.000189	0.000503	CcSEcCtD
Perindopril—Tension—Epirubicin—urinary bladder cancer	0.000188	0.0005	CcSEcCtD
Perindopril—Dysgeusia—Epirubicin—urinary bladder cancer	0.000188	0.000499	CcSEcCtD
Perindopril—Nervousness—Epirubicin—urinary bladder cancer	0.000186	0.000495	CcSEcCtD
Perindopril—Back pain—Epirubicin—urinary bladder cancer	0.000185	0.000493	CcSEcCtD
Perindopril—Angiopathy—Doxorubicin—urinary bladder cancer	0.000185	0.000492	CcSEcCtD
Perindopril—Malaise—Methotrexate—urinary bladder cancer	0.000185	0.000491	CcSEcCtD
Perindopril—Dizziness—Etoposide—urinary bladder cancer	0.000184	0.000491	CcSEcCtD
Perindopril—Muscle spasms—Epirubicin—urinary bladder cancer	0.000184	0.00049	CcSEcCtD
Perindopril—Vertigo—Methotrexate—urinary bladder cancer	0.000184	0.00049	CcSEcCtD
Perindopril—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000183	0.000489	CcSEcCtD
Perindopril—Leukopenia—Methotrexate—urinary bladder cancer	0.000183	0.000488	CcSEcCtD
Perindopril—Chills—Doxorubicin—urinary bladder cancer	0.000183	0.000486	CcSEcCtD
Perindopril—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000182	0.000484	CcSEcCtD
Perindopril—Nausea—Cisplatin—urinary bladder cancer	0.000181	0.000481	CcSEcCtD
Perindopril—Alopecia—Doxorubicin—urinary bladder cancer	0.00018	0.000479	CcSEcCtD
Perindopril—Cough—Methotrexate—urinary bladder cancer	0.000179	0.000476	CcSEcCtD
Perindopril—Mental disorder—Doxorubicin—urinary bladder cancer	0.000178	0.000475	CcSEcCtD
Perindopril—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000178	0.000473	CcSEcCtD
Perindopril—Vomiting—Etoposide—urinary bladder cancer	0.000177	0.000472	CcSEcCtD
Perindopril—Malnutrition—Doxorubicin—urinary bladder cancer	0.000177	0.000472	CcSEcCtD
Perindopril—Erythema—Doxorubicin—urinary bladder cancer	0.000177	0.000472	CcSEcCtD
Perindopril—Anaemia—Epirubicin—urinary bladder cancer	0.000177	0.000471	CcSEcCtD
Perindopril—Agitation—Epirubicin—urinary bladder cancer	0.000176	0.000469	CcSEcCtD
Perindopril—Rash—Etoposide—urinary bladder cancer	0.000176	0.000468	CcSEcCtD
Perindopril—Dermatitis—Etoposide—urinary bladder cancer	0.000176	0.000468	CcSEcCtD
Perindopril—Headache—Etoposide—urinary bladder cancer	0.000175	0.000465	CcSEcCtD
Perindopril—Flatulence—Doxorubicin—urinary bladder cancer	0.000175	0.000465	CcSEcCtD
Perindopril—Arthralgia—Methotrexate—urinary bladder cancer	0.000174	0.000464	CcSEcCtD
Perindopril—Myalgia—Methotrexate—urinary bladder cancer	0.000174	0.000464	CcSEcCtD
Perindopril—Chest pain—Methotrexate—urinary bladder cancer	0.000174	0.000464	CcSEcCtD
Perindopril—Tension—Doxorubicin—urinary bladder cancer	0.000174	0.000463	CcSEcCtD
Perindopril—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000174	0.000462	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000173	0.000461	CcSEcCtD
Perindopril—Malaise—Epirubicin—urinary bladder cancer	0.000173	0.00046	CcSEcCtD
Perindopril—Discomfort—Methotrexate—urinary bladder cancer	0.000172	0.000458	CcSEcCtD
Perindopril—Nervousness—Doxorubicin—urinary bladder cancer	0.000172	0.000458	CcSEcCtD
Perindopril—Vertigo—Epirubicin—urinary bladder cancer	0.000172	0.000458	CcSEcCtD
Perindopril—Syncope—Epirubicin—urinary bladder cancer	0.000172	0.000457	CcSEcCtD
Perindopril—Leukopenia—Epirubicin—urinary bladder cancer	0.000171	0.000457	CcSEcCtD
Perindopril—Back pain—Doxorubicin—urinary bladder cancer	0.000171	0.000456	CcSEcCtD
Perindopril—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00017	0.000454	CcSEcCtD
Perindopril—Palpitations—Epirubicin—urinary bladder cancer	0.000169	0.000451	CcSEcCtD
Perindopril—Confusional state—Methotrexate—urinary bladder cancer	0.000168	0.000448	CcSEcCtD
Perindopril—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000168	0.000448	CcSEcCtD
Perindopril—Cough—Epirubicin—urinary bladder cancer	0.000167	0.000445	CcSEcCtD
Perindopril—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000167	0.000445	CcSEcCtD
Perindopril—Nausea—Etoposide—urinary bladder cancer	0.000166	0.000441	CcSEcCtD
Perindopril—Hypertension—Epirubicin—urinary bladder cancer	0.000165	0.00044	CcSEcCtD
Perindopril—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000164	0.000438	CcSEcCtD
Perindopril—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000164	0.000436	CcSEcCtD
Perindopril—Anaemia—Doxorubicin—urinary bladder cancer	0.000164	0.000436	CcSEcCtD
Perindopril—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000164	0.000435	CcSEcCtD
Perindopril—Chest pain—Epirubicin—urinary bladder cancer	0.000163	0.000434	CcSEcCtD
Perindopril—Myalgia—Epirubicin—urinary bladder cancer	0.000163	0.000434	CcSEcCtD
Perindopril—Arthralgia—Epirubicin—urinary bladder cancer	0.000163	0.000434	CcSEcCtD
Perindopril—Agitation—Doxorubicin—urinary bladder cancer	0.000163	0.000434	CcSEcCtD
Perindopril—Anxiety—Epirubicin—urinary bladder cancer	0.000162	0.000433	CcSEcCtD
Perindopril—Skin disorder—Methotrexate—urinary bladder cancer	0.000162	0.000432	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000162	0.000431	CcSEcCtD
Perindopril—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000161	0.00043	CcSEcCtD
Perindopril—Discomfort—Epirubicin—urinary bladder cancer	0.000161	0.000429	CcSEcCtD
Perindopril—Malaise—Doxorubicin—urinary bladder cancer	0.00016	0.000426	CcSEcCtD
Perindopril—Dry mouth—Epirubicin—urinary bladder cancer	0.000159	0.000425	CcSEcCtD
Perindopril—Vertigo—Doxorubicin—urinary bladder cancer	0.000159	0.000424	CcSEcCtD
Perindopril—Anorexia—Methotrexate—urinary bladder cancer	0.000159	0.000424	CcSEcCtD
Perindopril—Syncope—Doxorubicin—urinary bladder cancer	0.000159	0.000423	CcSEcCtD
Perindopril—Leukopenia—Doxorubicin—urinary bladder cancer	0.000159	0.000422	CcSEcCtD
Perindopril—Confusional state—Epirubicin—urinary bladder cancer	0.000158	0.00042	CcSEcCtD
Perindopril—Palpitations—Doxorubicin—urinary bladder cancer	0.000157	0.000417	CcSEcCtD
Perindopril—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000156	0.000416	CcSEcCtD
Perindopril—Oedema—Epirubicin—urinary bladder cancer	0.000156	0.000416	CcSEcCtD
Perindopril—Hypotension—Methotrexate—urinary bladder cancer	0.000156	0.000416	CcSEcCtD
Perindopril—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000156	0.000415	CcSEcCtD
Perindopril—Cough—Doxorubicin—urinary bladder cancer	0.000155	0.000412	CcSEcCtD
Perindopril—Shock—Epirubicin—urinary bladder cancer	0.000154	0.00041	CcSEcCtD
Perindopril—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000153	0.000408	CcSEcCtD
Perindopril—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000153	0.000408	CcSEcCtD
Perindopril—Hypertension—Doxorubicin—urinary bladder cancer	0.000153	0.000407	CcSEcCtD
Perindopril—Tachycardia—Epirubicin—urinary bladder cancer	0.000153	0.000406	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000152	0.000405	CcSEcCtD
Perindopril—Skin disorder—Epirubicin—urinary bladder cancer	0.000152	0.000404	CcSEcCtD
Perindopril—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000151	0.000402	CcSEcCtD
Perindopril—Insomnia—Methotrexate—urinary bladder cancer	0.000151	0.000402	CcSEcCtD
Perindopril—Arthralgia—Doxorubicin—urinary bladder cancer	0.000151	0.000402	CcSEcCtD
Perindopril—Chest pain—Doxorubicin—urinary bladder cancer	0.000151	0.000402	CcSEcCtD
Perindopril—Myalgia—Doxorubicin—urinary bladder cancer	0.000151	0.000402	CcSEcCtD
Perindopril—Anxiety—Doxorubicin—urinary bladder cancer	0.00015	0.0004	CcSEcCtD
Perindopril—Paraesthesia—Methotrexate—urinary bladder cancer	0.00015	0.000399	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00015	0.000399	CcSEcCtD
Perindopril—Discomfort—Doxorubicin—urinary bladder cancer	0.000149	0.000397	CcSEcCtD
Perindopril—Anorexia—Epirubicin—urinary bladder cancer	0.000149	0.000397	CcSEcCtD
Perindopril—Dyspnoea—Methotrexate—urinary bladder cancer	0.000149	0.000397	CcSEcCtD
Perindopril—Somnolence—Methotrexate—urinary bladder cancer	0.000148	0.000395	CcSEcCtD
Perindopril—Dry mouth—Doxorubicin—urinary bladder cancer	0.000148	0.000393	CcSEcCtD
Perindopril—Dyspepsia—Methotrexate—urinary bladder cancer	0.000147	0.000392	CcSEcCtD
Perindopril—Hypotension—Epirubicin—urinary bladder cancer	0.000146	0.000389	CcSEcCtD
Perindopril—Confusional state—Doxorubicin—urinary bladder cancer	0.000146	0.000388	CcSEcCtD
Perindopril—Decreased appetite—Methotrexate—urinary bladder cancer	0.000145	0.000387	CcSEcCtD
Perindopril—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000145	0.000385	CcSEcCtD
Perindopril—Oedema—Doxorubicin—urinary bladder cancer	0.000145	0.000385	CcSEcCtD
Perindopril—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000144	0.000384	CcSEcCtD
Perindopril—Fatigue—Methotrexate—urinary bladder cancer	0.000144	0.000383	CcSEcCtD
Perindopril—Pain—Methotrexate—urinary bladder cancer	0.000143	0.00038	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000142	0.000379	CcSEcCtD
Perindopril—Shock—Doxorubicin—urinary bladder cancer	0.000142	0.000379	CcSEcCtD
Perindopril—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000142	0.000378	CcSEcCtD
Perindopril—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000142	0.000377	CcSEcCtD
Perindopril—Insomnia—Epirubicin—urinary bladder cancer	0.000141	0.000376	CcSEcCtD
Perindopril—Tachycardia—Doxorubicin—urinary bladder cancer	0.000141	0.000376	CcSEcCtD
Perindopril—Skin disorder—Doxorubicin—urinary bladder cancer	0.00014	0.000374	CcSEcCtD
Perindopril—Paraesthesia—Epirubicin—urinary bladder cancer	0.00014	0.000374	CcSEcCtD
Perindopril—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00014	0.000372	CcSEcCtD
Perindopril—Dyspnoea—Epirubicin—urinary bladder cancer	0.000139	0.000371	CcSEcCtD
Perindopril—Somnolence—Epirubicin—urinary bladder cancer	0.000139	0.00037	CcSEcCtD
Perindopril—Anorexia—Doxorubicin—urinary bladder cancer	0.000138	0.000367	CcSEcCtD
Perindopril—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000138	0.000367	CcSEcCtD
Perindopril—Dyspepsia—Epirubicin—urinary bladder cancer	0.000138	0.000366	CcSEcCtD
Perindopril—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000137	0.000364	CcSEcCtD
Perindopril—Decreased appetite—Epirubicin—urinary bladder cancer	0.000136	0.000362	CcSEcCtD
Perindopril—Hypotension—Doxorubicin—urinary bladder cancer	0.000135	0.00036	CcSEcCtD
Perindopril—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000135	0.000359	CcSEcCtD
Perindopril—Fatigue—Epirubicin—urinary bladder cancer	0.000135	0.000359	CcSEcCtD
Perindopril—Pain—Epirubicin—urinary bladder cancer	0.000134	0.000356	CcSEcCtD
Perindopril—Constipation—Epirubicin—urinary bladder cancer	0.000134	0.000356	CcSEcCtD
Perindopril—Urticaria—Methotrexate—urinary bladder cancer	0.000133	0.000353	CcSEcCtD
Perindopril—Abdominal pain—Methotrexate—urinary bladder cancer	0.000132	0.000352	CcSEcCtD
Perindopril—Body temperature increased—Methotrexate—urinary bladder cancer	0.000132	0.000352	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000132	0.000351	CcSEcCtD
Perindopril—Insomnia—Doxorubicin—urinary bladder cancer	0.000131	0.000348	CcSEcCtD
Perindopril—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00013	0.000346	CcSEcCtD
Perindopril—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000129	0.000343	CcSEcCtD
Perindopril—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000129	0.000343	CcSEcCtD
Perindopril—Somnolence—Doxorubicin—urinary bladder cancer	0.000129	0.000342	CcSEcCtD
Perindopril—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000128	0.00034	CcSEcCtD
Perindopril—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000127	0.000339	CcSEcCtD
Perindopril—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000126	0.000335	CcSEcCtD
Perindopril—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000125	0.000333	CcSEcCtD
Perindopril—Fatigue—Doxorubicin—urinary bladder cancer	0.000125	0.000332	CcSEcCtD
Perindopril—Urticaria—Epirubicin—urinary bladder cancer	0.000124	0.000331	CcSEcCtD
Perindopril—Pain—Doxorubicin—urinary bladder cancer	0.000124	0.000329	CcSEcCtD
Perindopril—Constipation—Doxorubicin—urinary bladder cancer	0.000124	0.000329	CcSEcCtD
Perindopril—Abdominal pain—Epirubicin—urinary bladder cancer	0.000124	0.000329	CcSEcCtD
Perindopril—Body temperature increased—Epirubicin—urinary bladder cancer	0.000124	0.000329	CcSEcCtD
Perindopril—Asthenia—Methotrexate—urinary bladder cancer	0.00012	0.000319	CcSEcCtD
Perindopril—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000119	0.000317	CcSEcCtD
Perindopril—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000118	0.000315	CcSEcCtD
Perindopril—Pruritus—Methotrexate—urinary bladder cancer	0.000118	0.000315	CcSEcCtD
Perindopril—Urticaria—Doxorubicin—urinary bladder cancer	0.000115	0.000306	CcSEcCtD
Perindopril—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000114	0.000304	CcSEcCtD
Perindopril—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000114	0.000304	CcSEcCtD
Perindopril—Diarrhoea—Methotrexate—urinary bladder cancer	0.000114	0.000304	CcSEcCtD
Perindopril—Asthenia—Epirubicin—urinary bladder cancer	0.000112	0.000299	CcSEcCtD
Perindopril—Pruritus—Epirubicin—urinary bladder cancer	0.000111	0.000294	CcSEcCtD
Perindopril—Dizziness—Methotrexate—urinary bladder cancer	0.00011	0.000294	CcSEcCtD
Perindopril—Diarrhoea—Epirubicin—urinary bladder cancer	0.000107	0.000285	CcSEcCtD
Perindopril—Vomiting—Methotrexate—urinary bladder cancer	0.000106	0.000283	CcSEcCtD
Perindopril—Rash—Methotrexate—urinary bladder cancer	0.000105	0.00028	CcSEcCtD
Perindopril—Dermatitis—Methotrexate—urinary bladder cancer	0.000105	0.00028	CcSEcCtD
Perindopril—Headache—Methotrexate—urinary bladder cancer	0.000105	0.000279	CcSEcCtD
Perindopril—Asthenia—Doxorubicin—urinary bladder cancer	0.000104	0.000276	CcSEcCtD
Perindopril—Dizziness—Epirubicin—urinary bladder cancer	0.000103	0.000275	CcSEcCtD
Perindopril—Pruritus—Doxorubicin—urinary bladder cancer	0.000102	0.000272	CcSEcCtD
Perindopril—Vomiting—Epirubicin—urinary bladder cancer	9.94e-05	0.000265	CcSEcCtD
Perindopril—Nausea—Methotrexate—urinary bladder cancer	9.92e-05	0.000264	CcSEcCtD
Perindopril—Diarrhoea—Doxorubicin—urinary bladder cancer	9.89e-05	0.000264	CcSEcCtD
Perindopril—Rash—Epirubicin—urinary bladder cancer	9.85e-05	0.000262	CcSEcCtD
Perindopril—Dermatitis—Epirubicin—urinary bladder cancer	9.84e-05	0.000262	CcSEcCtD
Perindopril—Headache—Epirubicin—urinary bladder cancer	9.79e-05	0.000261	CcSEcCtD
Perindopril—Dizziness—Doxorubicin—urinary bladder cancer	9.56e-05	0.000255	CcSEcCtD
Perindopril—Nausea—Epirubicin—urinary bladder cancer	9.28e-05	0.000247	CcSEcCtD
Perindopril—Vomiting—Doxorubicin—urinary bladder cancer	9.19e-05	0.000245	CcSEcCtD
Perindopril—Rash—Doxorubicin—urinary bladder cancer	9.12e-05	0.000243	CcSEcCtD
Perindopril—Dermatitis—Doxorubicin—urinary bladder cancer	9.11e-05	0.000243	CcSEcCtD
Perindopril—Headache—Doxorubicin—urinary bladder cancer	9.06e-05	0.000241	CcSEcCtD
Perindopril—Nausea—Doxorubicin—urinary bladder cancer	8.59e-05	0.000229	CcSEcCtD
